FOSL2 and neoplasm: Dimers of FOS (c‐FOS, FOS‐B, FRA‐1/FOSL1 and FRA‐2/FOSL2) and JUN (c‐JUN, JUN‐B, and JUN‐D) build the AP1 complex, which can drive tumor progression and treatment resistance.7